|
Delayed
Nasdaq Stockholm
03:00:00 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 8.750 SEK | -1.69% |
|
-2.67% | -35.19% |
| 08-13 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 08-13 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 98.54M 10.4M 8.92M 8.35M 7.63M 14.4M 992M 14.54M 38.36M 500M 39.06M 38.21M 1.66B | P/E 2026 * |
-2.96x | P/E 2027 * | -2.46x |
|---|---|---|---|---|---|
| Enterprise Value | 90.54M 9.56M 8.19M 7.68M 7.01M 13.23M 911M 13.36M 35.24M 460M 35.89M 35.11M 1.52B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | -1.69% | ||
| 1 week | -2.67% | ||
| Current month | +4.42% | ||
| 1 month | +0.57% | ||
| 3 months | -29.21% | ||
| 6 months | +7.89% | ||
| Current year | -35.19% |
| 1 week | 8.7 |  | 9.01 |
| 1 month | 8.26 | | 9.14 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 2023-01-22 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 2026-06-30 |
| Chief Tech/Sci/R&D Officer | 39 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 2022-05-24 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 2019-09-25 |
Pål Ryfors
BRD | Director/Board Member | 43 | 2022-05-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/25/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 3/24/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 12/20/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.69% | -2.67% | -64.43% | -62.69% | 10.4M | |
| -1.06% | +0.65% | +77.42% | +122.82% | 1,100B | |
| +0.04% | +0.75% | +53.10% | +64.29% | 658B | |
| +0.48% | +2.65% | +28.06% | +81.19% | 470B | |
| +0.48% | +2.10% | +44.71% | +44.74% | 372B | |
| +0.15% | +1.04% | +26.82% | +41.99% | 304B | |
| -0.30% | +3.17% | +4.72% | +15.07% | 264B | |
| -0.36% | +3.99% | +53.31% | +72.49% | 239B | |
| +1.71% | +4.42% | -10.90% | -51.63% | 213B | |
| +1.38% | +3.72% | +30.33% | +93.56% | 184B | |
| Average | +0.09% | +2.59% | +24.31% | +42.18% | 380.29B | |
| Weighted average by Cap. | -0.06% | +2.21% | +46.10% | +71.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.27M -2.8M -2.63M -2.4M -4.53M -312M -4.58M -12.07M -157M -12.29M -12.02M -521M | -40M -4.22M -3.62M -3.39M -3.1M -5.85M -403M -5.9M -15.57M -203M -15.86M -15.51M -673M |
| Net Debt | -8M -845K -724K -678K -620K -1.17M -80.53M -1.18M -3.11M -40.63M -3.17M -3.1M -135M | -17M -1.79M -1.54M -1.44M -1.32M -2.48M -171M -2.51M -6.62M -86.33M -6.74M -6.59M -286M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | SEK 8.750 | -1.69% | 466 |
| 26-08-25 | SEK 8.900 | +2.18% | 4,986 |
| 26-08-24 | SEK 8.710 | -1.25% | 8,515 |
| 26-08-21 | SEK 8.820 | -0.45% | 7,547 |
| 26-08-20 | SEK 8.860 | -1.45% | 6,741 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
